VOR
Vor Biopharma Inc.
$24.11
-$0.89(-3.56%)
30
Overall
40
Value
18
Tech
34
Quality
Market Cap
$5.91B
Volume
224.54K
52W Range
$2.62 - $65.80
Target Price
$59.50
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $69.0M | $93.4M | $126.0M | $121.2M | ||
| Research & Development | $47.5M | $64.5M | $94.3M | $93.3M | ||
| Research Expense | $47.5M | $64.5M | $94.3M | $93.3M | ||
| Selling, General & Administrative | $21.5M | $28.9M | $31.7M | $27.9M | ||
| General & Administrative Expenses | $21.5M | $28.9M | $31.7M | $27.9M | ||
| Salaries & Wages | -- | -- | $13.4M | $9.8M | ||
| Depreciation & Amortization | $1.4M | $2.5M | $3.5M | $3.5M | ||
| Depreciation & Amortization | $1.4M | $2.5M | $3.5M | $3.5M | ||
| Other Operating Expenses | $4.2M | $8.2M | $10.4M | $10.5M | ||
| OPERATING INCOME | ||||||
| Operating income | $-69.0M | $-93.4M | $-126.0M | $-121.2M | ||
| EBITDA | $-67.5M | $-89.6M | $-122.5M | $-114.6M | ||
| NON-OPERATING ITEMS | ||||||
| Intinc | $119.0K | $1.3M | $8.2M | $4.3M | ||
| Net Non-Operating Interest Income/Expense | $119.0K | $1.3M | $8.2M | $4.3M | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-68.9M | $-92.1M | $-126.0M | $-116.9M | ||
| Pre-Tax Income | $-68.9M | $-92.1M | $-117.9M | $-116.9M | ||
| NET INCOME | ||||||
| Net Income | $-68.9M | $-92.1M | $-117.9M | $-116.9M | ||
| Net Income (Continuing Operations) | $-68.9M | $-92.1M | $-117.9M | $-116.9M | ||
| Net Income (Discontinued Operations) | $-68.9M | $-92.1M | $-117.9M | $-116.9M | ||
| Net Income (Common Stockholders) | $-70.1M | $-92.1M | $-117.9M | $-116.9M | ||
| Normalized Income | $-54.4M | -- | -- | $-115.7M | ||
| TOTALS | ||||||
| Total Expenses | $69.0M | $93.4M | $126.0M | $121.2M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $33.4M | $39.6M | $67.2M | $68.7M | ||
| Average Shares Outstanding (Diluted) | -- | $39.6M | $67.2M | $68.7M | ||
| Shares Outstanding | $37.5M | $66.4M | $68.2M | $124.9M | ||
| Basic EPS | $-2.1 | $-2.33 | $-1.75 | $-1.7 | ||
| Basic EPS (Continuing Operations) | $-2.1 | $-2.33 | $-1.75 | $-1.7 | ||
| Diluted EPS | $-2.1 | $-2.33 | $-1.75 | $-1.7 | ||
| Diluted EPS (Continuing Operations) | -- | $-2.33 | $-1.75 | $-1.7 | ||
| OTHER METRICS | ||||||
| Accrued Preferred Stock Dividends | $1.2M | -- | -- | -- | ||
| Other Gand A | $21.5M | $28.9M | $31.7M | $27.9M | ||
| Otherunder Preferred Stock Dividend | $1.2M | -- | -- | -- | ||
| Preferred Stock Dividends | $1.2M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VOR | $24.11 | -3.6% | 224.54K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |